PubMed · 11562291
Recent developments on ketolides and macrolides.
Abstract
Recent semi-synthetic studies of erythromycin A culminated in the discovery of two ketolide drug candidates, HMR-3647 and ABT-773, for the treatment of community-acquired bacterial infections caused by both macrolide- and beta-lactam-susceptible and -resistant S. pneumoniae, gram negative bacteria, and intracellular atypical pathogens. The discovery of ketolides has rekindled interest in macrolides, and recent efforts have also led to a novel class of 4''-carbamates with activity against macrolide-resistant organisms. This review is an account of recent developments on ketolides and macrolides in terms of both chemistry and antibacterial activity.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Y J Wu, W G Su. 2001. Recent developments on ketolides and macrolides.. https://doi.org/10.2174/0929867013371671
Cite the original work for its findings. Save a collection to share your selection of sources.